全球未矫正屈光不正市场 – 行业趋势及 2030 年预测

未矫正屈光不正市场分析和规模

发达国家和发展中国家近视、远视、散光和老花眼等屈光不正的患病率不断上升，预计将在预测期内促进市场增长。此外，预计主要医疗机构和政府机构将开展越来越多的主动活动，以进一步推动市场发展。

Data Bridge Market Research 分析称，全球未矫正屈光不正市场预计在预测期内将经历 6.41% 的复合年增长率。这表明市场价值。由于近视病例不断增加、可支配收入增加以及针对未矫正屈光不正的先进医疗基础设施的存在，“近视”在未矫正屈光不正市场类型细分市场中占据主导地位。除了对市场价值、增长率、细分市场、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

未矫正屈光不正市场范围和细分

Market Definition

Uncorrected refractive error (URE) is referred to as refractive error which is not screened, diagnosed, or treated. The growing pervasiveness of uncorrected refractive error is leading to inducing visual impairment. For instance, according to the World Health Organization’s data, nearly 95 million people belonging to age-group 50 years and above are visually impaired caused owing to uncorrected refractive errors. Consequently, it is also illustrating the future enormous demand market.

Global Uncorrected Refractive Errors Market Dynamics

Drivers

• Increase in the Incidence of Refractive Errors such as Myopia, Hypermetropia, Astigmatism, and Presbyopia

Growing prevalence of refractive errors such as myopia, hypermetropia, astigmatism, and presbyopia and the availability of effective products of the companies involved in research and development of Uncorrected refractive errors accelerate the market growth. The rising disease burden is primarily driving the uncorrected refractive errors industry, which results in a significant margin in the rise of uncorrected refractive error usage.

The World Health Organization (WHO), in its latest global statistics, has revealed that there are 37 million blind people, including 1.4 million children under the age of 15, and 125 million with severely impaired vision, resulting in a total of over 160 million visually impaired people.

• Rise in Rapid and Early Diagnosis of Refractive Errors

Refractive eye conditions like astigmatism, phoria, and accommodative dysfunctions can cause a reduction in the visual performance of the child and lead to ocular symptoms like eyestrain, headaches, blurred vision, and intermittent double vision. The high prevalence of significant refractive error and the costs associated with its correction, with spectacles, contact lenses, or surgery, pose significant public health and economic concerns.

Moreover, a growing number of initiative activities by major healthcare organizations and government bodies is anticipated to propel further market development. 

• Growing Awareness Regarding the Disease and Treatment

Growing awareness levels amongst patients and physicians pertaining to the applications is presumed to be contributing toward market growth. The aforementioned factor is believed to boost the adoption of a wide range of products which is expected to boost the uncorrected refractive errors market over the forecast period.

Awareness about the Refractive error, its associated symptoms along with different treatment modalities can play an important role in the prevention of blindness. An Informed public is more likely to be focused on prevention programs. There is no complete and documented survey on the perception and insight of the people about the awareness of Refractive Errors and their correction methods. Thus, an increase in product approvals for addressing the high demand for diagnosis of treatment may contribute to the growth of the respective market.

Opportunities

Furthermore, the rising demand for advanced technologies also boosts up the market growth which will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. The space has the presence of advanced technology. Rising healthcare expenditure in developing countries will further contribute by generating immense opportunities that will further expand the market's growth rate in the future. 

A growing number of initiative activities by major healthcare organizations and government bodies is anticipated to propel further market development. Moreover, concern for optical health and rising per capita income in middle income countries act as opportunities for market growth.

Restraints/Challenges

On the other hand, the lack of accessibility of screening and diagnosis of eye examination is expected to obstruct the uncorrected refractive errors market growth in the above mentioned projected timeframe. Moreover, lack of affordability is projected to challenge the uncorrected refractive errors market in the forecast period of 2023-2030.

This Uncorrected refractive errors market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the uncorrected refractive errors market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In April 2019, Zydus Cadila announced the strategic partnership with SIFI S.p.A. The primary purpose of this strategic partnership is to market innovative surgical products and intraocular lenses in the Indian market. This strategy has helped the company to strengthen its footprints in the Indian market.

Global Uncorrected Refractive Errors Market Scope

未矫正屈光不正市场根据类型、症状和治疗类型进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

类型

• 近视
• 远视/远视
• 老花眼
• 散光

症状

• 视力模糊或扭曲
• 头痛
• 眯眼和眼睛疲劳
• 阅读困难
• 双重视觉
• 明亮灯光下的“光环”
• 朦胧

治疗类型

• 眼镜
• 隐形眼镜
• 外科手术

全球未矫正屈光不正市场区域分析/见解

对未矫正屈光不正市场进行分析，并按国家、类型、症状和治疗类型提供市场规模洞察和趋势。

未矫正屈光不正市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。  

由于医疗费用高昂、民众的眼保健教育意识增强、以及对未矫正屈光不正的报销政策优惠，预计北美将在未矫正屈光不正市场占据主导地位。

预计亚太地区在 2023 年至 2030 年的预测期内将以最高的增长率增长，这得益于该地区关于眼保健健康的不同宣传计划的数量不断增加。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析以及案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税的影响以及贸易路线。   

医疗保健基础设施增长安装基础和新技术渗透

未矫正屈光不正市场还为您提供了详细的市场分析，包括每个国家/地区资本设备医疗保健支出的增长、未矫正屈光不正市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对未矫正屈光不正市场的影响。数据适用于 2010-2021 年的历史时期。

竞争格局和未矫正屈光不正市场份额分析

未矫正屈光不正市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对未矫正屈光不正市场的关注有关。

未矫正屈光不正市场的一些主要参与者包括：

• 雅培医疗光学公司（美国）
• 卡尔蔡司公司（德国）
• 爱尔康公司（瑞士）
• 博士伦公司（加拿大）
• Topcon株式会社（日本）
• Ellex Medical Lasers Limited（美国）
• Lumenis Ltd.（美国）
• SCHWIND eye-tech-solutions GmbH & Co. KG（德国）
• Ziemer Ophthalmic Systems AG（瑞士）
• 尼德克有限公司（美国）
• 强生视力（美国）

SKU-59385